Shaanxi Kanghui Pharmaceutical Co., Ltd. (603139.SS)

CNY 15.72

(-1.63%)

Revenue Summary of Shaanxi Kanghui Pharmaceutical Co., Ltd.

  • Shaanxi Kanghui Pharmaceutical Co., Ltd.'s latest annual revenue in 2023 was 672.96 Million CNY , up 36.92% from previous year.
  • Shaanxi Kanghui Pharmaceutical Co., Ltd.'s latest quarterly revenue in 2024 Q3 was 136.37 Million CNY , up 2.84% from previous quarter.
  • Shaanxi Kanghui Pharmaceutical Co., Ltd. reported a annual revenue of 491.51 Million CNY in annual revenue 2022, up 11.01% from previous year.
  • Shaanxi Kanghui Pharmaceutical Co., Ltd. reported a annual revenue of 442.75 Million CNY in annual revenue 2021, up 6.93% from previous year.
  • Shaanxi Kanghui Pharmaceutical Co., Ltd. reported a quarterly revenue of 135.04 Million CNY for 2024 Q2, up 9.03% from previous quarter.
  • Shaanxi Kanghui Pharmaceutical Co., Ltd. reported a quarterly revenue of 136.37 Million CNY for 2024 Q3, up 2.84% from previous quarter.

Annual Revenue Chart of Shaanxi Kanghui Pharmaceutical Co., Ltd. (2023 - 2012)

Historical Annual Revenue of Shaanxi Kanghui Pharmaceutical Co., Ltd. (2023 - 2012)

Year Revenue Revenue Growth
2023 672.96 Million CNY 36.92%
2022 491.51 Million CNY 11.01%
2021 442.75 Million CNY 6.93%
2020 414.07 Million CNY -4.02%
2019 431.42 Million CNY 14.86%
2018 375.61 Million CNY 2.33%
2017 367.05 Million CNY -3.87%
2016 381.84 Million CNY 0.54%
2015 379.78 Million CNY 1.08%
2014 375.73 Million CNY 14.53%
2013 328.06 Million CNY 18.51%
2012 276.82 Million CNY 0.0%

Peer Revenue Comparison of Shaanxi Kanghui Pharmaceutical Co., Ltd.

Name Revenue Revenue Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. 9.65 Billion CNY 93.03%
Yabao Pharmaceutical Group Co., Ltd 2.9 Billion CNY 76.872%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 75.51 Billion CNY 99.109%
Harbin Pharmaceutical Group Co., Ltd. 15.33 Billion CNY 95.613%
Tasly Pharmaceutical Group Co., Ltd 8.54 Billion CNY 92.125%
Zhejiang Medicine Co., Ltd. 7.79 Billion CNY 91.366%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 8.22 Billion CNY 91.815%
Lionco Pharmaceutical Group Co.,Ltd. 196.83 Million CNY -241.897%
Humanwell Healthcare (Group) Co.,Ltd. 24.33 Billion CNY 97.234%
Ginwa Enterprise (Group) Inc. 565.4 Million CNY -19.023%
Joincare Pharmaceutical Group Industry Co.,Ltd. 16.64 Billion CNY 95.957%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 644.97 Million CNY -4.34%
China Animal Husbandry Industry Co., Ltd. 5.4 Billion CNY 87.552%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 860.93 Million CNY 21.834%
Zhejiang Huahai Pharmaceutical Co., Ltd. 8.21 Billion CNY 91.805%
Shanghai Haoyuan Chemexpress Co., Ltd. 1.87 Billion CNY 64.058%
Ningbo Menovo Pharmaceutical Co., Ltd. 1.21 Billion CNY 44.681%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 5.52 Billion CNY 87.816%
Chongqing Taiji Industry(Group) Co.,Ltd 15.43 Billion CNY 95.64%
HPGC Renmintongtai Pharmaceutical Corporation 10.38 Billion CNY 93.523%
Nanjing Well Pharmaceutical Group Co.,Ltd. 1.15 Billion CNY 41.777%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 3.73 Billion CNY 81.979%
Henan Lingrui Pharmaceutical Co., Ltd. 3.31 Billion CNY 79.678%
Shenzhen Chipscreen Biosciences Co., Ltd. 515.78 Million CNY -30.473%
Guizhou Yibai Pharmaceutical Co., Ltd. 2.77 Billion CNY 75.775%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 4.86 Billion CNY 86.175%
Zhongzhu Healthcare Holding Co.,Ltd 580.05 Million CNY -16.016%
Beijing Tongrentang Co., Ltd 17.86 Billion CNY 96.232%
KPC Pharmaceuticals, Inc. 7.62 Billion CNY 91.178%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 845.34 Million CNY 20.392%
North China Pharmaceutical Company Ltd. 10.12 Billion CNY 93.35%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 10.22 Billion CNY 93.417%
Tibet Weixinkang Medicine Co., Ltd. 1.32 Billion CNY 49.12%
China National Medicines Corporation Ltd. 49.69 Billion CNY 98.646%
Zhejiang Hisun Pharmaceutical Co., Ltd. 10.37 Billion CNY 93.512%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 3.13 Billion CNY 78.556%
ChengDu ShengNuo Biotec Co.,Ltd. 430.98 Million CNY -56.144%
Dali Pharmaceuticalco.,Ltd 87.26 Million CNY -671.125%
Changchun BCHT Biotechnology Co. 1.81 Billion CNY 62.854%
Zhejiang Shengda Bio-Pharm Co., Ltd. 727.4 Million CNY 7.485%
Shanghai Jiaoda Onlly Co.,Ltd 291.91 Million CNY -130.53%
Jiang Zhong Pharmaceutical Co.,Ltd 4.32 Billion CNY 84.449%
Mayinglong Pharmaceutical Group Co., LTD. 3.13 Billion CNY 78.546%
Cisen Pharmaceutical Co., Ltd. 4.46 Billion CNY 84.919%
Hunan Warrant Pharmaceutical Co.,Ltd 1.43 Billion CNY 53.031%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 41.39 Billion CNY 98.374%
Jianmin Pharmaceutical Group Co.,Ltd. 4.18 Billion CNY 83.916%
Hunan Fangsheng Pharmaceutical Co., Ltd. 1.62 Billion CNY 58.677%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 3.09 Billion CNY 78.267%
Guobang Pharma Ltd. 5.34 Billion CNY 87.42%
Kangmei Pharmaceutical Co., Ltd. 4.87 Billion CNY 86.193%
Shandong Buchang Pharmaceuticals Co., Ltd. 13.24 Billion CNY 94.919%
Zhejiang Starry Pharmaceutical Co.,Ltd. 2.17 Billion CNY 69.095%
Henan Taloph Pharmaceutical Stock Co.,Ltd 2.06 Billion CNY 67.488%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 3.79 Billion CNY 82.283%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 3.93 Billion CNY 82.882%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 932.12 Million CNY 27.803%
Shanghai Shyndec Pharmaceutical Co., Ltd. 11.93 Billion CNY 94.36%
Shanghai Yizhong Pharmaceutical Co., Ltd. 360.25 Million CNY -86.802%
Tibet Rhodiola Pharmaceutical Holding Co. 3.09 Billion CNY 78.265%
Sichuan Huiyu Pharmaceutical Co., Ltd. 920.34 Million CNY 26.88%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 671.62 Million CNY -0.199%
CanSino Biologics Inc. 345.18 Million CNY -94.958%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 2.17 Billion CNY 69.046%
Shandong Lukang Pharmaceutical Co.,Ltd. 6.14 Billion CNY 89.052%